These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4994134)

  • 1. [Recent progress in chemotherapy of tuberculosis].
    Fegiz G
    Policlinico Prat; 1969 May; 76(18):573-83. PubMed ID: 4994134
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro activities of antitubercular agents and intensification of combined chemotherapy of tuberculosis].
    Ooizumi K
    Kekkaku; 1983 Sep; 58(9):490-2. PubMed ID: 6420602
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of newly detected cases of pulmonary tuberculosis prior to the results of determining the drug sensitivity of Mycobacterium tuberculosis].
    Rudoĭ NM; Krivenko GT
    Probl Tuberk; 1988; (11):24-8. PubMed ID: 3146752
    [No Abstract]   [Full Text] [Related]  

  • 4. [Determination of Mycobacterium tuberculosis' sensitivity to pyrazinamide on a BACTEC-960 bacteriological analyzer].
    Irtuganova OA; Smirnova NS; Slogotskaia LV
    Probl Tuberk Bolezn Legk; 2003; (7):40-2. PubMed ID: 12939878
    [No Abstract]   [Full Text] [Related]  

  • 5. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
    Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
    Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of laboratory and clinical antitubercular agent sensitivity tests].
    Popovic J; Praso R; Stosic Z; Davidovic C
    Plucne Bolesti Tuberk; 1971; 23(4):333-8. PubMed ID: 5004987
    [No Abstract]   [Full Text] [Related]  

  • 7. [Short-course chemotherapy of pulmonary tuberculosis and several problems concerning its use, especially in India].
    Fox W
    Bull Int Union Tuberc; 1985; 60(1-2):44-54. PubMed ID: 3935193
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug resistance of Mycobacterium tuberculosis. Behavior of the phenomenon during the past 10 years].
    Daddi G; Lucchesi M; Maldarizzi B; Mancini P; Termine A
    Ann Ist Carlo Forlanini; 1969; 29(4):286-300. PubMed ID: 5004328
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening of terpenes and derivatives for antimycobacterial activity; identification of geranylgeraniol and geranylgeranyl acetate as potent inhibitors of Mycobacterium tuberculosis in vitro.
    Vik A; James A; Gundersen LL
    Planta Med; 2007 Oct; 73(13):1410-2. PubMed ID: 17924309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Laboratory data on pulmonary tuberculosis of recent vertification].
    Gelli G; Malaguzzi Valeri F
    G Pneumol; 1970 Dec; 14(4):228-36. PubMed ID: 5005067
    [No Abstract]   [Full Text] [Related]  

  • 11. The hunt for the elusive surrogate marker of sterilizing activity in tuberculosis treatment.
    Burman WJ
    Am J Respir Crit Care Med; 2003 May; 167(10):1299-301. PubMed ID: 12738594
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of secondary chemoresistance of Koch bacillus at the present time].
    Jemna I; Lego I
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(4):243-4. PubMed ID: 6278569
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current possibilities of the use of the so-called minor antimycobacterial agents].
    Grassi C
    G Ital Mal Torace; 1971; 25(6):301-12. PubMed ID: 5005062
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental trials and clinical observations on the use of intravenous morphazinamide in chronic pulmonary tuberculosis].
    Di Perna A; Berti R; Cinotti D
    Minerva Med; 1965 Sep; 56(71):2872-8. PubMed ID: 4954934
    [No Abstract]   [Full Text] [Related]  

  • 16. Is second-line anti-tuberculosis drug susceptibility testing reliable?
    Kim SJ; Espinal MA; Abe C; Bai GH; Boulahbal F; Fattorin L; Gilpin C; Hoffner S; Kam KM; Martin-Casabona N; Rigouts L; Vincent V
    Int J Tuberc Lung Dis; 2004 Sep; 8(9):1157-8. PubMed ID: 15455606
    [No Abstract]   [Full Text] [Related]  

  • 17. [Shorter treatment of pulmonary tuberculosis is only acceptable with at least 4 drugs in the initial combination of tuberculostatic agents].
    Veen J
    Ned Tijdschr Geneeskd; 1996 Nov; 140(44):2164-7. PubMed ID: 8984351
    [No Abstract]   [Full Text] [Related]  

  • 18. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.
    Diacon AH; Patientia RF; Venter A; van Helden PD; Smith PJ; McIlleron H; Maritz JS; Donald PR
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2994-6. PubMed ID: 17517849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complex research studies in the testing of the effectiveness of phenaside].
    Sel'tsovskiĭ PP; Irtuganova OA; Slogotskaia LV; Smirnova NS; Moroz AM; Borzenko AS; Spasov AA; Smirnova LA; Dzhura PI; Karpov AV; Ivanovskiĭ VB; Pauker MN; Plemiannikova GI
    Probl Tuberk; 2001; (8):29-31. PubMed ID: 11767386
    [No Abstract]   [Full Text] [Related]  

  • 20. [Impact of drug resistance on the fitness of Mycobacteruim tuberculosis of the genotype W-Beijing].
    Tungusova OS; Mar'iandyshev AO; Kaugant DA; Sandven P; Bjeune G
    Probl Tuberk Bolezn Legk; 2005; (8):46-50. PubMed ID: 16209021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.